Literatūras saraksts:

  • 1. R. Firantienė et al. „Magnio stokos organizme klinikiniai aspektai”, Medicinos teorija ir praktika 2012, Nr. 4.1, p. 356
    2. Gums J. „Magnesium in cardiovascular and oter disorders”, Am J Health-Syst Pharm, 2004, 61: 1569-76
    3. Chakraborti S et al. „Protective role of magnesium in cardiovascular diseases: a review”, Mol Cell Biochem, 2002, 238:163-79
    4. Schechter M. „Does magnesium have a role in the treatment of patients with coronary artery disease?” Am J Cardiovasc Drugs 2003, 3:231-39
    5. Sojka, J. „Magnesium supplementation and osteoporosis”, Nutrition Review 1995, 53:71-80
    6. Toba Y. et al. „Dietary magnesium supplementation affects bone metabolism and dynamic strength of bone in ovarietomized rats”, J Nutr, 2000, 130:216-20
    7. Stendig-Lindberg G. et al. „Experimentally included prolonged magnesium deficiency causes osteoporosis in the rat”, Eur J Intern Med, 2004, 15:97-107
    8. Jee S et al. „The effect of magnesium on blood pressure: a meta-analysis of randomized clinical trials”, Am J Hypertens, 2002, 15:691-96
    9. Barbagallo M et al. „Altered ionic effects of insulin in hypertension: role of basal ion levels in determining cellular responsiveness”, J Clin Endocrinol Metab, 1997, 82:1761-65
    10. Barbagallo M et al. „Diabetes mellitus, hypertension and ageing: the ionic hypothesis of ageing and cardiovascular-metabolic diseases”, Diabetes Metab, 1997, 23:281-94
    11. Lopez-Ridaura R. et al. „Magesium intake and risk of type 2 diabetes in men and women”, Diabetes Care, 2004, 27:134-40
    12. Barbagallo M. et al. „Role of Magnesium in insulin action, diabetes and cardiometabolic sindrome X”, Mol Aspects Med, 2003, 24:39-52
    13. Song Y. et al. „Dietary magnesium intake in relation to plasma insulin levels and risk of type 2 diabetes in women”, Diabetes Care, 2004, 27:59-65
    14. Maier J et al. “Low magnesium promotes endothelial cell dysfunction: implications for atherosclerosis, inflammation and thrombosis”, Biochim Biophys Acta, 2004, 1689:13-21
    15. Rayssiguier Y Mazur A. “Magnesium and inflammation: lessons from animal models”, Clin Calcium, 2005, 15:245-48
    16. Malpuech-Brugere C et al. “Inflammatory response following acute magnesium deficiency in the rat”, Biochim Biophys Acta, 2000, 1501:91-98
    17. Sinert R et al. “The ratio of ionized calcium to magnesium modifies the bronchodilatory effects of magnesium therapy in acute asthma”, Acad Emergency Med, 2002, 9:436-47
    18. Gilliland F et al. “Dietary magnesium, potassium, sodium and children's lung function”, Am J Epidemiol, 2002, 155:125-31
    19. Dominguez L. et al. “Bronchial reactivity and intracellular magnesium: a possible mechanism for the bronchodilating effects of magnesium in asthma”, Clin Sci, 1998, 95:137-42
    20. Seelig M. “Consequences of magnesium deficiency on the enhancement of stress reactions; preventive and therapeutic implications (a review)”, J Am Coll Nutr, 1994, 13:429-46
    21. Galland L. “Magnesium, stress and neuropsychiatric disorders”, Magnes Trace Elem, 1991, 10:287-301
    22. Golf S et al. “On the significance of magnesium in extreme physical stress”, Cardiovasc Drugs Ther, 1998, 12 (Supp12):197-202
    23. Mocci F et al. “The effect of noise on serum and urinary magnesium and catecholamines in humans”, Occup Med, 2001, 51:56-61
    24. Attias J et al. “Preventing noise-induced otoacoustic emission loss by increasing magnesium (Mg2+) intake in guinea pigs”, J Basic Clin Physiol Pharmacol, 2003, 14:119-36
    25. Nageris B et al. “Magnesium treatment for sudden hearing loss”, Ann Otol Rhino! Larygngol, 2004, 113:672¬75
    26. Larsson S et al. “Magnesium intake in relation to risk of colorectal cancer”, JAMA, 2005, 293:86-89
    27. Ema M et al. “Alcohol-induced vascular damage of brain is ameliorated by administration of magnesium”, Alcohol, 1998, 15:95-103
    28. Wester P. “Magnesium”, Am J Clin Nutr, 1987, 45:1305-12
    29. Grazzi L et al. “Magnesium as a treatment for paediatric tension-type headache: a clinical replication series”, Neurol Sci, 2005, 25:338-41
    30. Mauskop A et al. “Serum ionized magnesium levels and serum ionized calcium/ionized magnesium levels in women with menstrual migraine”, Headache, 2002, 42:242-48
    31. Kozielec T Starobrat-Hermelin B. “Assessment of magnesium levels in children with attention deficit hyperactivity disorder (ADHD)”, Magnes Res, 1997, 10:143-48
    32. Starobrat-Hermelin B Kozielec T. “The effects of magnesium physiological supplementation on hyperactivity in children with attention deficit hyperactivity disorder (ADHD). Positive response to magnesium oral loading test”, Magnes Res, 1997, 10:149-56
    33. Mousain-Bosc M et al. “Magnesium vitamin B-6 intake reduces central nervous system hyperexcitability in children”, J Am Coll Nutr, 2004, 23:5455-485
    34. Murray M. “Encyclopedia of Nutritional Supplements”, Prima Pub, Roseville CA, 1996. Pg 172.
    35. Guerrero-Romera F Rodriguez-Moran M. “Low serum magnesium levels and metabolic syndrome”, Acta Diabetol, 2002, 39:209-13
    36. Chaudhary D et al. “Studies on the development of an insulin resistant rat model by chronic feeding of low magnesium high sucrose diet”, Magnes Res, 2004, 17:293-300
    37. Stipanuk M. “Biochemical and Physiological Aspects of Human Nutrition”, Saunders, Philadelphia, 2000. P 671-86
    38. Shechter M. et al. “Oral magnesium therapy improves endothelial function in patients with coronary artery disease”, Circ, 2000, 102:2353-5